Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Recruiting now · Phase 1/Phase 2

Conditions studied: Idiopathic Pulmonary Hemosiderosis, Leflunomide

In brief

The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare the control group treated with stroid to see if the efficacy of Leflunomide would be better than control group.

Key facts

Study ID
NCT05937191
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
People needed
34
Starts
2023-06-01
Expected to finish
2026-12-31
Last updated by the study team
2023-07-10

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.